For DNMT3B −2437T>A polymorphism, when TT genotype was used as reference, the A-allele carrier genotypes (AT+AA) were not remarkably related to lung cancer risk (OR = 0.99, 95% CI, 0.74 to 1.33, P = 0.168). This evidence concerns the gene DNMT3B and lung carcinoma.